000			02040 a2200565 4500
005			20250515151543.0
264		0	_c20090226
008			200902s 0 0 eng d
022			_a1473-5830
024	7		_a10.1097/MCA.0b013e32831a8811 _2doi
040			_aNLM _beng _cNLM
100	1		_aWestphal, Sabine
245	0	0	_aDifferent galenic formulations of fluvastatin have equal lipid-lowering potential but differ in reducing lipemia-induced endothelial dysfunction. _h[electronic resource]
260			_bCoronary artery disease _cJan 2009
300			_a81-5 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial
650	0	4	_aAdministration, Oral
650	0	4	_aAged
650	0	4	_aBrachial Artery _xdrug effects
650	0	4	_aCapsules
650	0	4	_aChemistry, Pharmaceutical
650	0	4	_aCross-Over Studies
650	0	4	_aDelayed-Action Preparations
650	0	4	_aDietary Fats _xadministration & dosage
650	0	4	_aDouble-Blind Method
650	0	4	_aDrug Administration Schedule
650	0	4	_aEndothelium, Vascular _xdiagnostic imaging
650	0	4	_aFatty Acids, Monounsaturated _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aFluvastatin
650	0	4	_aHumans
650	0	4	_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xadministration & dosage
650	0	4	_aHyperlipidemias _xblood
650	0	4	_aIndoles _xadministration & dosage
650	0	4	_aMale
650	0	4	_aMetabolic Syndrome _xdiagnostic imaging
650	0	4	_aMiddle Aged
650	0	4	_aPostprandial Period
650	0	4	_aRegional Blood Flow
650	0	4	_aTablets
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
650	0	4	_aTriglycerides _xblood
650	0	4	_aUltrasonography
650	0	4	_aVasodilation _xdrug effects
700	1		_aAbletshauser, Claudia
700	1		_aLuley, Claus
773	0		_tCoronary artery disease _gvol. 20 _gno. 1 _gp. 81-5
856	4	0	_uhttps://doi.org/10.1097/MCA.0b013e32831a8811 _zAvailable from publisher's website
999			_c18514670 _d18514670